Barclays’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.44B | Buy |
1,563,625
+159,958
| +11% | +$162M | 0.35% | 33 |
|
|
2025
Q4 | $1.51B | Sell |
1,403,667
-107,091
| -7% | -$102M | 0.36% | 32 |
|
|
2025
Q3 | $1.15B | Buy |
1,510,758
+6,359
| +0.4% | +$4.73M | 0.25% | 49 |
|
|
2025
Q2 | $1.17B | Sell |
1,504,399
-269,968
| -15% | -$210M | 0.27% | 40 |
|
|
2025
Q1 | $1.47B | Buy |
1,774,367
+205,156
| +13% | +$171M | 0.42% | 26 |
|
|
2024
Q4 | $1.21B | Buy |
1,569,211
+7,325
| +0.5% | +$6.07M | 0.34% | 32 |
|
|
2024
Q3 | $1.38B | Sell |
1,561,886
-506,845
| -25% | -$456M | 0.37% | 25 |
|
|
2024
Q2 | $1.87B | Sell |
2,068,731
-38,166
| -2% | -$30.5M | 0.57% | 20 |
|
|
2024
Q1 | $1.64B | Sell |
2,106,897
-484,394
| -19% | -$345M | 0.57% | 25 |
|
|
2023
Q4 | $1.51B | Buy |
2,591,291
+526,547
| +26% | +$307M | 0.55% | 22 |
|
|
2023
Q3 | $1.11B | Buy |
2,064,744
+549,719
| +36% | +$283M | 0.69% | 16 |
|
|
2023
Q2 | $711M | Buy |
1,515,025
+905,548
| +149% | +$380M | 0.45% | 41 |
|
|
2023
Q1 | $209M | Sell |
609,477
-909,465
| -60% | -$307M | 0.1% | 132 |
|
|
2022
Q4 | $556M | Buy |
1,518,942
+366,307
| +32% | +$130M | 0.25% | 52 |
|
|
2022
Q3 | $373M | Buy |
1,152,635
+320,937
| +39% | +$102M | 0.41% | 40 |
|
|
2022
Q2 | $270M | Sell |
831,698
-356,733
| -30% | -$107M | 0.16% | 87 |
|
|
2022
Q1 | $340M | Sell |
1,188,431
-1,583,991
| -57% | -$408M | 0.27% | 78 |
|
|
2021
Q4 | $766M | Buy |
2,772,422
+877,346
| +46% | +$222M | 0.29% | 65 |
|
|
2021
Q3 | $438M | Buy |
1,895,076
+693,851
| +58% | +$171M | 0.2% | 79 |
|
|
2021
Q2 | $276M | Buy |
1,201,225
+143,363
| +14% | +$28.8M | 0.13% | 122 |
|
|
2021
Q1 | $198M | Buy |
1,057,862
+202,620
| +24% | +$39.6M | 0.11% | 153 |
|
|
2020
Q4 | $144M | Buy |
855,242
+24,139
| +3% | +$3.6M | 0.08% | 201 |
|
|
2020
Q3 | $123M | Buy |
831,103
+215,157
| +35% | +$33.3M | 0.07% | 189 |
|
|
2020
Q2 | $101M | Sell |
615,946
-179,319
| -23% | -$27.5M | 0.08% | 191 |
|
|
2020
Q1 | $110M | Sell |
795,265
-560,737
| -41% | -$77M | 0.09% | 146 |
|
|
2019
Q4 | $178M | Sell |
1,356,002
-158,534
| -10% | -$18.4M | 0.1% | 162 |
|
|
2019
Q3 | $169M | Sell |
1,514,536
-103,660
| -6% | -$11.5M | 0.11% | 151 |
|
|
2019
Q2 | $179M | Buy |
1,618,196
+382,464
| +31% | +$45M | 0.11% | 156 |
|
|
2019
Q1 | $160M | Buy |
1,235,732
+198,970
| +19% | +$24.2M | 0.11% | 147 |
|
|
2018
Q4 | $120M | Sell |
1,036,762
-322,708
| -24% | -$36M | 0.09% | 152 |
|
|
2018
Q3 | $146M | Buy |
1,359,470
+84,369
| +7% | +$8.43M | 0.1% | 148 |
|
|
2018
Q2 | $109M | Sell |
1,275,101
-267,103
| -17% | -$21.9M | 0.09% | 177 |
|
|
2018
Q1 | $119M | Buy |
1,542,204
+429,605
| +39% | +$34.6M | 0.09% | 184 |
|
|
2017
Q4 | $94M | Buy |
1,112,599
+561,514
| +102% | +$47.8M | 0.08% | 211 |
|
|
2017
Q3 | $47.1M | Buy |
551,085
+42,554
| +8% | +$3.49M | 0.05% | 315 |
|
|
2017
Q2 | $41.9M | Sell |
508,531
-569,873
| -53% | -$46.5M | 0.04% | 329 |
|
|
2017
Q1 | $90.7M | Buy |
1,078,404
+317,582
| +42% | +$25.4M | 0.1% | 155 |
|
|
2016
Q4 | $56M | Sell |
760,822
-668,566
| -47% | -$49.8M | 0.06% | 252 |
|
|
2016
Q3 | $115M | Buy |
1,429,388
+798,310
| +126% | +$63.9M | 0.13% | 119 |
|
|
2016
Q2 | $49.7M | Buy |
631,078
+12,685
| +2% | +$955K | 0.06% | 257 |
|
|
2016
Q1 | $44.5M | Sell |
618,393
-22,446
| -4% | -$1.7M | 0.07% | 247 |
|
|
2015
Q4 | $53.8M | Sell |
640,839
-85,072
| -12% | -$7.06M | 0.07% | 256 |
|
|
2015
Q3 | $60.3M | Sell |
725,911
-391,473
| -35% | -$33M | 0.07% | 229 |
|
|
2015
Q2 | $92.7M | Sell |
1,117,384
-382,978
| -26% | -$29.2M | 0.1% | 158 |
|
|
2015
Q1 | $108M | Buy |
1,500,362
+56,114
| +4% | +$3.99M | 0.12% | 142 |
|
|
2014
Q4 | $98.2M | Buy |
1,444,248
+174,714
| +14% | +$11.8M | 0.09% | 170 |
|
|
2014
Q3 | $81.3M | Sell |
1,269,534
-66,566
| -5% | -$4.21M | 0.08% | 203 |
|
|
2014
Q2 | $82.8M | Sell |
1,336,100
-122,478
| -8% | -$7.31M | 0.09% | 183 |
|
|
2014
Q1 | $84.6M | Sell |
1,458,578
-412,183
| -22% | -$23M | 0.1% | 182 |
|
|
2013
Q4 | $95.4M | Buy |
1,870,761
+62,096
| +3% | +$3.11M | 0.1% | 167 |
|
|
2013
Q3 | $90.4M | Buy |
1,808,665
+180,274
| +11% | +$9.44M | 0.11% | 141 |
|
|
2013
Q2 | $80M | Buy |
+1,628,391
| New | +$88.6M | 0.1% | 150 |
|
Other funds holding LLY
VCM
VPM
Barclays's LLY Position: Q1 2026 in Review
Barclays increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $162M and bringing the position to 1,563,625 shares worth $1.44B. The position accounts for 0.35% of the portfolio, ranked #33.
Barclays first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.87B in Q2 2024. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Barclays held 1,563,625 shares of Eli Lilly worth $1.44B as of Q1 2026.
- Barclays bought 159,958 Eli Lilly shares in Q1 2026, an estimated $162M.
- Eli Lilly made up 0.35% of Barclays's portfolio in Q1 2026, its #33 holding.
- Barclays first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Barclays's Eli Lilly position peaked at $1.87B in Q2 2024.
- 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.